Therapeutic doses of topiramate are not toxic to the developing rat brain

被引:119
作者
Glier, C
Dzietko, M
Bittigau, P
Jarosz, B
Korobowicz, E
Ikonomidou, C
机构
[1] Humboldt Univ, Charite, Dept Pediat Neurol, Virchow Clin, D-13353 Berlin, Germany
[2] Humboldt Univ, Charite, Dept Neonatol, Virchow Clin, D-13353 Berlin, Germany
[3] Med Univ Lublin, Dept Clin Pathol, PL-20950 Lublin, Poland
关键词
topiramate; toxic; rat brain;
D O I
10.1016/j.expneurol.2004.01.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Antiepileptic drugs (AEDs) used to treat seizures in pregnant women, infants, and young children may cause cognitive impairment. One of the implicated mechanisms is enhancement of apoptotic neuronal death, which occurs physiologically in the developing brain. We investigated whether topiramate, one of the newer antiepileptic drugs, has neurotoxic properties in the developing rat brain. Topiramate slightly but significantly enhanced apoptotic neuronal death in the 7-day-old rat brain at doses of 50 mg/kg and above. These doses are several folds higher than reported ED50 doses in infant rodent seizure models that respond to topiramate. Electron microscopy confirmed that dying neurons following topiramate treatment displayed the same morphological features as neurons undergoing physiological cell death during development. When compared to the neurotoxicity profile of phenytoin, valproate, and phenobarbital, the separation between the effective anticonvulsant dose and the neurotoxic dose was greater for topiramate and the neurotoxic effect was lower. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 48 条
[1]   Melanocortin receptors mediate alpha-MSH-induced stimulation of neurite outgrowth in Neuro 2A cells [J].
Adan, RAH ;
vanderKraan, M ;
Doornbos, RP ;
Bar, PR ;
Burbach, JPH .
MOLECULAR BRAIN RESEARCH, 1996, 36 (01) :37-44
[2]   Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures [J].
Ängehagen, M ;
Ben-Menachem, E ;
Rönnbäck, L ;
Hansson, E .
EPILEPSY RESEARCH, 2003, 54 (01) :63-71
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   Antiepileptic drugs and apoptosis in the developing brain [J].
Bittigau, P ;
Sifringer, M ;
Ikonomidou, C .
NEUROPROTECTIVE AGENTS, 2003, 993 :103-114
[5]   Antiepileptic drugs and apoptotic neurodegeneration in the developing brain [J].
Bittigau, P ;
Sifringer, M ;
Genz, K ;
Reith, E ;
Pospischil, D ;
Govindarajalu, S ;
Dzietko, M ;
Pesditschek, S ;
Mai, I ;
Dikranian, K ;
Olney, JW ;
Ikonomidou, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :15089-15094
[6]   Chronic management of seizures in the syndromes of idiopathic generalized epilepsy [J].
Bourgeois, BFD .
EPILEPSIA, 2003, 44 :27-32
[7]   Drug therapy - Antiepileptic drugs [J].
Brodie, MJ ;
Dichter, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :168-175
[8]   PRENATAL PREDICTION OF RISK OF THE FETAL HYDANTOIN SYNDROME [J].
BUEHLER, BA ;
DELIMONT, D ;
VANWAES, M ;
FINNELL, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) :1567-1572
[9]   IMPROVED CUPRIC-SILVER METHOD FOR IMPREGNATION OF AXONAL AND TERMINAL DEGENERATION [J].
DEOLMOS, JS ;
INGRAM, WR .
BRAIN RESEARCH, 1971, 33 (02) :523-&
[10]   Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems [J].
Dessens, AB ;
Cohen-Kettenis, PT ;
Mellenbergh, GJ ;
Koppe, JG ;
van de Poll, NE ;
Boer, K .
ACTA PAEDIATRICA, 2000, 89 (05) :533-541